Philadelphia chromosome-positive acute lymphoblastic leukemia
Information
- Disease name
- Philadelphia chromosome-positive acute lymphoblastic leukemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03709017 | Active, not recruiting | Iclusig PMS in CML or Ph+ALL Patients | August 7, 2018 | June 2023 | |
| NCT02081378 | Completed | Phase 1 | A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL | April 24, 2014 | March 14, 2023 |
| NCT03647215 | Completed | CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey | December 18, 2017 | June 30, 2021 | |
| NCT03678454 | Completed | Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium | February 3, 2017 | March 31, 2022 |